UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
E E0 E6 E7 EA EB EC ED EE EF EG EH EI EJ EK EL EM EN EO EP EQ ER ES ET EU EV EW EX EY
ES ESA ESC ESE ESH ESI ESK ESO ESP ESR ESS EST ESU ESW
selected terms: 198 page 1 of 2

1. 1,3,5(10)-Estratrien-2,3-diol-17-one
(UMLS (NCI) C0046200) =Steroid; Pharmacologic Substance ;
51. Esophageal Cancer Stage IVA
(UMLS (NCI) C1336336) Stage IVA Carcinoma of Esophagus;
Stage IVA Carcinoma of the Esophagus;
Stage IVA Esophageal Cancer;
Stage IVA Esophageal Carcinoma;
Stage IVA Esophagus Carcinoma =Neoplastic Process
2. 1,3,5(10)-Estratrien-3-ol-17-one
[aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen; converted from androstenedione directly, or from testosterone via estradiol; in humans, it is produced primarily by the cyclic ovaries, placenta, and the adipose tissue of men and postmenopausal women. ( CSP )] (UMLS (NCI) C0014942) =Steroid; Pharmacologic Substance; Hormone =17-Ketosteroids;
Estrenes;
[HS300] ESTROGENS;
=Estrone Hydrogen Sulfate compound with Piperazine(1:1);
Estrone Sodium Sulfate;
ESTRONE 1.5 MG;
ESTRONE 1.5 MG/ML;
ESTRONE 2 MG/ML;
ESTRONE 2.5 MG;
ESTRONE 5 MG/ML;
ESTRONE 2 MG
52. Esophageal Cancer Stage IVB
(UMLS (NCI) C1336366) Stage IVB Carcinoma of Esophagus;
Stage IVB Carcinoma of the Esophagus;
Stage IVB Esophageal Cancer;
Stage IVB Esophageal Carcinoma;
Stage IVB Esophagus Carcinoma =Neoplastic Process
3. E-stopped
(UMLS (HL7) C1550005) =Idea or Concept =Equipment state;
53. Esophageal Carcinoma, Recurrent
[An esophageal cancer which has reappeared after a period of remission or after presumed treatment. ( NCI )] (UMLS (NCI) C0854761) Oesophageal Carcinoma Recurrent;
Recurrent Cancer of Esophagus;
Recurrent Cancer of the Esophagus;
Recurrent Carcinoma of Esophagus;
Recurrent Carcinoma of the Esophagus;
Recurrent Esophageal Cancer;
Recurrent Esophageal Carcinoma;
Recurrent Esophagus Cancer;
Relapsed Cancer of Esophagus;
Relapsed Cancer of the Esophagus;
Relapsed Carcinoma of Esophagus;
Relapsed Carcinoma of the Esophagus;
Relapsed Esophageal Cancer;
Relapsed Esophagus Carcinoma =Neoplastic Process
4. Es
[Supernumerary maxillary right central primary incisor ( HL7V3.0 )] (UMLS (HL7) C1552150) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
54. ESOPHAGEAL DX PROC NEC
[ ] (UMLS (ICD9CM) C0176727) =Diagnostic Procedure
5. ES
[A country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France. (NCI) ( NCI )] (UMLS (NCI) C0037747) =Geographic Area ;
55. Esophageal Dysplasia
[A lesion that is characterized by architectural and cytologic abnormalities of the esophageal epithelium, and carries a predisposition for progression to invasive carcinoma. Intraepithelial neoplasia (dysplasia) of the esophagus is graded as low or high grade. In this two-tier system, severe dysplasia and carcinoma in situ are included under the rubric of high grade intraepithelial neoplasia and may have the same clinical implications. (WHO, 2000) — 2003 ( NCI )] (UMLS (NCI) C0586354) =Disease or Syndrome
6. ESAPRAZOLE
(UMLS (NCI) C0059583) =Organic Chemical; Pharmacologic Substance ;
56. Esophageal Epidermoid Carcinoma
[A squamous cell carcinomas arising from the esophagus. It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30. The median age is around 65 in both males and females. It is located mostly in the middle and lower third of the esophagus. Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described. The microscopic features are the same as in other squamous cell carcinomas. Any degree of differentiation may occur, and variation within a single tumor is common. The prognosis is poor. —2002 ( NCI )] (UMLS (NCI) C0279626) =Neoplastic Process
7. escape reaction
[innate response elicited by sensory stimuli associated with a threatening situation, or actual confrontation with an enemy. ( CSP )] (UMLS (CSP) C0014832) =Individual Behavior ;
=behavior;
57. Esophageal Epithelium
(UMLS (NCI) C1179544) =Body Part, Organ, or Organ Component ;
8. Escape Risk
(UMLS (HL7) C1548764) =Intellectual Product =Risk Codes;
◊ [The entity is at risk for escaping from containment or control. ( HL7V3.0 )] (UMLS (HL7) C1551399) Idea or Concept EntityRisk;
58. Esophageal Fibroma
[A benign neoplasm arising from the fibrous soft tissue of the esophagus. The tumor is characterized by the presence of spindle-shaped fibroblasts. ( NCI )] (UMLS (NCI) C1333445) Fibroma of Esophagus;
Fibroma of the Esophagus;
=Neoplastic Process
9. Escherichia
[genus of gram negative, facultatively anaerobic, rod shaped bacteria found in the large intestine of warm blooded animals; nonpathogenic or opportunistic. ( CSP )] (UMLS (CSP) C0014833) =Bacterium ;
=coliform bacilli;
=E. coli;
59. Esophageal Gastrointestinal Stromal Tumor
[Located most frequently in the lower esophagus and begin as intramural lesions. Predominantly occurs in older males. Dysphagia is the usual complaint. Most tumors are clinically malignant, and commonly develop liver metastases. (WHO, 2000) — 2003 ( NCI )] (UMLS (NCI) C1333446) Esophageal GIST;
=Neoplastic Process
10. Escherichia coli 0157:H7
[serotype of Escherichia coli which produces a shiga toxin; infection causes hemolytic uremic syndrome. ( CSP )] (UMLS (CSP) C0872040) =Bacterium ;
=E. coli;
60. Esophageal Gland
(UMLS (NCI) C0227178) =Body Part, Organ, or Organ Component
11. Escherichia coli k12
[strain of Escherichia coli bacteria much used in studies of bacterial genetics. ( CSP )] (UMLS (CSP) C0596533) =Bacterium ;
=E. coli;
61. Esophageal Glandular Intraepithelial Neoplasia
(UMLS (NCI) C1333447) =Neoplastic Process
12. Escherichia coli k12 lambda
[ ] (UMLS (CSP) C0596534) =Bacterium ;
62. ESOPHAGEAL GRAFT NEC
[ ] (UMLS (ICD9CM) C0176749) =Therapeutic or Preventive Procedure
13. escort
[Only with Transportation services. A person who escorts the patient. ( HL7V3.0 )] (UMLS (HL7) C1550481) =Idea or Concept =ParticipationAncillary;
63. Esophageal Granular Cell Myoblastoma
[A tumor that usually presents with small nodules or small sessile polyps, predominantly in the distal esophagus. Histologically, they are composed of sheets of oval to polygonal cells with a small central nucleus and abundant granular cytoplasm. This is usually a benign tumor. (WHO, 2000) — 2003 ( NCI )] (UMLS (NCI) C1333448) Esophageal Granular Cell Neoplasm;
Esophageal Granular Cell Tumor;
Granular Cell Esophageal Tumor;
Granular Cell Esophagus Myoblastoma;
Granular Cell Esophagus Neoplasm;
Granular Cell Esophagus Tumor;
Granular Cell Myoblastoma of Esophagus;
Granular Cell Myoblastoma of the Esophagus;
Granular Cell Neoplasm of Esophagus;
Granular Cell Neoplasm of the Esophagus;
Granular Cell Tumor of Esophagus;
Granular Cell Tumor of the Esophagus =Neoplastic Process
14. Escort Required
(UMLS (HL7) C1547632) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Required;
Unknown;
Not Required
64. Esophageal hemorrhage
(UMLS (ICD9CM) C0239293) =Finding
15. Esculamine
(UMLS (NCI) C0059587) =Carbohydrate; Pharmacologic Substance ;
65. Esophageal High-Grade Glandular Intraepithelial Neoplasia
(UMLS (NCI) C1333449) High-Grade Esophageal Glandular Intraepithelial Neoplasia;
=Neoplastic Process
16. ESERIDINE
(UMLS (NCI) C0771595) =Organic Chemical; Pharmacologic Substance
66. Esophageal High-Grade Intraepithelial Neoplasia
[A lesion in which the architectural and cytologic abnormalities involve both the lower and the upper half of the esophageal mucosa. It includes lesions termed moderate dysplasia, and carcinoma in situ (severe dysplasia). (WHO, 2000) — 2003 ( NCI )] (UMLS (NCI) C1333450) =Neoplastic Process
17. eserine
[ ] (UMLS (CSP) C1314787) =Organic Chemical; Pharmacologic Substance ;
67. Esophageal High-Grade Squamous Intraepithelial Neoplasia
(UMLS (NCI) C1333451) High-Grade Esophageal Squamous Intraepithelial Neoplasia;
=Neoplastic Process
18. ESHAP Regimen
[A regimen consisting of etoposide, methylprednisolone, high-dose cytarabine and cisplatin used to treat relapsed and refractory Hodgkin's and non-Hodgkin's lymphoma. ( NCI )] (UMLS (NCI) C0384397) =Therapeutic or Preventive Procedure
68. Esophageal Hodgkin Lymphoma
(UMLS (NCI) C1333452) Esophageal Hodgkin's Disease;
Esophageal Hodgkin's Lymphoma;
Esophagus Hodgkin Lymphoma;
Esophagus Hodgkin's Disease;
Esophagus Hodgkin's Lymphoma;
Hodgkin's Disease of Esophagus;
Hodgkin's Disease of the Esophagus;
Hodgkin's Lymphoma of Esophagus;
Hodgkin's Lymphoma of the Esophagus;
Primary Esophageal Hodgkin's Lymphoma =Neoplastic Process
19. Esiak
[An herbal formula containing burdock root (Arctium lappa), Turkey rhubarb root (Rheum palmatum), sheep sorrel (Rumex acetosella), and slippery elm bark (Ulmus fulva) with potential immunostimulating, anti-inflammatory and anti-tumor activities. The extract's chemical profile, their respective concentrations and the mechanism of action of Essiac are largely unknown due to the proprietary nature of the formula and product inconsistency. Several chemical classes in Essiac are consistently represented and may attribute to its therapeutic effect, including anthraquinone derivatives such as rhein and emodin, high molecular polysaccharides, and lignans such as arctigenin. However, all these chemicals are unlikely to occur in high concentrations in Essiac, and its potential therapeutic effect may be attributed to a potential synergistic effect of these various compounds. ( NCI )] (UMLS (NCI) C0673827) =Pharmacologic Substance; Biologically Active Substance
69. ESOPHAGEAL INCISION NEC
[ ] (UMLS (ICD9CM) C0176721) =Therapeutic or Preventive Procedure
20. Eskalith
(UMLS (NCI) C0700753) =Pharmacologic Substance; Inorganic Chemical
70. Esophageal Kaposi Sarcoma
[A Kaposi sarcoma arising from the esophagus. ( NCI )] (UMLS (NCI) C1333453) Esophageal Kaposi's Sarcoma;
Esophagus Kaposi's Sarcoma;
Kaposi's Sarcoma of Esophagus;
Kaposi's Sarcoma of the Esophagus =Neoplastic Process
21. Eskimo
[Eskimo- a person having origins from the Eskimo indigenous group of Alaska and their descendants and who maintains tribal affiliation, or community or cultural attachment. ( NCI )] (UMLS (NCI) C0014845) =Population Group ;
=Alaska Indian;
=Greenland Eskimo;
Inupiat Eskimo;
Siberian Eskimo;
Yupik Eskimo
71. Esophageal Leiomyoma
[A benign smooth muscle neoplasm arising from the lower part of the esophagus. It is the most common mesenchymal neoplasm of the esophagus. Dysphagia is a frequent clinical symptom. ( NCI )] (UMLS (NCI) C0238114) =Neoplastic Process ;
22. EskimoAleut
(UMLS (HL7) C1698681) =Language ;
=AmericanIndianAlaskaNativeLanguages;
=Aleut;
Eskimoan
72. Esophageal Leiomyosarcoma
[An aggressive malignant smooth muscle neoplasm, arising from the esophagus. It is characterized by a proliferation of neoplastic spindle cells. ( NCI )] (UMLS (NCI) C1333454) Esophagus Leiomyosarcoma;
Leiomyosarcoma of Esophagus;
Leiomyosarcoma of the Esophagus;
=Neoplastic Process
23. Eskimoan
(UMLS (HL7) C1699894) =Language ;
=EskimoAleut;
=InuitInupiaq;
SirenikskiYupik
73. ESOPHAGEAL LEUKOPLAKIA
[ ] (UMLS (ICD9CM) C0267095) =Neoplastic Process
24. ESO-1 Peptide Vaccine
[A cancer vaccine consisting of an immunogenic peptide sequence from the cancer-testis antigen ESO-1, an antigen found in normal testis and various tumors, including melanoma, breast, bladder, prostate, and hepatocellular cancers. Vaccination with ESO-1 peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte response against tumor cells that express ESO-1. (NCI04) ( NCI )] (UMLS (NCI) C1134528) NY-ESO-1 Peptide Vaccine =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
74. Esophageal Lipoma
[A benign adipose tissue neoplasm of the esophagus. Clinical presentation includes obstruction, dysphagia, regurgitation, vomiting and reflux. It may be associated with aspiration and consecutive respiratory infections. ( NCI )] (UMLS (NCI) C1333455) Lipoma of Esophagus;
Lipoma of the Esophagus =Neoplastic Process
25. Esomeprazole Magnesium
[The magnesium salt of esomeprazole, an S-isomer of omeprazole and a proton pump inhibitor, with antacid activity. Esomeprazole inhibits the enzymatic activity of hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) on the gastric parietal cell. In the acidic compartment of the parietal cells, esomeprazole is protonated and converted into its active molecule, the achiral sulphenamide, which reacts and forms covalent bondages with H+/K+-ATPase, thereby interferes with the final step in the gastric acid production. ( NCI )] (UMLS (NCI) C0937622) ESOMEPRAZOLE MAGNESIUM PREPARATION =Organic Chemical; Pharmacologic Substance =ESOMEPRAZOLE;
Unclassified Ingredients =ESOMEPRAZOLE MAGNESIUM 40 MG;
ESOMEPRAZOLE MAGNESIUM 20 MG
75. Esophageal Liposarcoma
[A malignant adipose tissue neoplasm of the esophagus, characterized by multivacuolated lipoblasts with hyperchromatic nuclei, a solid pattern of growth, and a rich vascular network. It arises from the mucosal and submucosal layers of the lower esophagus. Clinical presentation includes progressive dysphagia, nausea, throat discomfort, and foreign body sensation. ( NCI )] (UMLS (NCI) C1333456) Esophagus Liposarcoma;
Liposarcoma of Esophagus;
Liposarcoma of the Esophagus;
=Neoplastic Process
26. Esomeprazole Sodium
(UMLS (NCI) C1337241) ESOMEPRAZOLE SODIUM UNIDENTIFIED;
ESOMEPRAZOLE SODIUM UNIDENTIFIED =Organic Chemical; Pharmacologic Substance
76. Esophageal Low Grade Glandular Intraepithelial Neoplasia
(UMLS (NCI) C1333457) Low Grade Esophageal Glandular Intraepithelial Neoplasia;
=Neoplastic Process
27. Esonarimod
(UMLS (NCI) C1175003) =Organic Chemical; ;
77. Esophageal Low Grade Intraepithelial Neoplasia
[A lesion in which the architectural and cytologic abnormalities are confined to the lower half of the esophageal epithelium. (WHO, 2000) — 2003 ( NCI )] (UMLS (NCI) C0586355) =Disease or Syndrome
28. ESOPH FISTULA REPAIR NEC
[ ] (UMLS (ICD9CM) C0869277) Repair of esophageal fistula, not elsewhere classified;
=Therapeutic or Preventive Procedure
78. Esophageal Low Grade Squamous Intraepithelial Neoplasia
(UMLS (NCI) C1333458) Low Grade Esophageal Squamous Intraepithelial Neoplasia;
=Neoplastic Process
29. ESOPH POUCH EXTERIORIZAT
[ ] (UMLS (ICD9CM) C0192336) =Therapeutic or Preventive Procedure
79. Esophageal Lymphoma
[Primary esophageal lymphomas are infrequent. Esophageal involvement is usually secondary from the mediastinum, lymph nodes, or a primary gastric location. Patients are usually males, middle aged or elderly. Dysphagia may be the presenting symptom. Large cell lymphomas and B-cell lymphomas of the mucosa-associated lymphoid tissue are the most commonly seen morphologic variants. (WHO, 2000) — 2003 ( NCI )] (UMLS (NCI) C1333459) Esophagus Lymphoma;
Lymphoma of Esophagus;
Lymphoma of the Esophagus;
Primary Esophageal Lymphoma =Neoplastic Process
30. ESOPH VARICE OTH DIS NOS
[ ] (UMLS (ICD9CM) C0155793) =Disease or Syndrome ;
80. ESOPHAGEAL MANOMETRY
[ ] (UMLS (ICD9CM) C0199873) =Diagnostic Procedure
31. ESOPH VARICES W/O BLEED
[ ] (UMLS (ICD9CM) C0267092) =Disease or Syndrome
81. Esophageal Mass
(UMLS (NCI) C0577008) =Finding
32. ESOPHAG SPEECH TRAINING
(UMLS (ICD9CM) C0014864) =Therapeutic or Preventive Procedure ;
82. Esophageal Melanoma
[A melanoma affecting the esophageal wall. Melanoma in the esophagus is more commonly metastatic than primary. Primary melanomas of the esophagus are polypoid and clinically aggressive. (WHO, 2000) — 2003 ( NCI )] (UMLS (NCI) C1333460) Esophagus Melanoma;
Melanoma of Esophagus;
Melanoma of the Esophagus;
=Neoplastic Process
33. ESOPHAG STRICTURE REPAIR
[ ] (UMLS (ICD9CM) C0192324) =Therapeutic or Preventive Procedure
83. Esophageal Metastasis
(UMLS (NCI) C0686055) =Neoplastic Process
34. ESOPHAG VARICES W BLEED
[ ] (UMLS (ICD9CM) C0155789) =Disease or Syndrome ;
84. esophageal motility
[ ] (UMLS (CSP) C0920509) esophagus motility =Organ or Tissue Function
35. Esophageal Adenocarcinoma, Recurrent
[Esophageal adenocarcinoma that reappears after treatment. ( NCI )] (UMLS (NCI) C0854762) Oesophageal Adenocarcinoma Recurrent;
Recurrent Adenocarcinoma of Esophagus;
Recurrent Adenocarcinoma of the Esophagus;
Recurrent Esophageal Adenocarcinoma;
Recurrent Esophagus Adenocarcinoma;
Relapsed Adenocarcinoma of Esophagus;
Relapsed Adenocarcinoma of the Esophagus;
Relapsed Esophageal Adenocarcinoma;
Relapsed Esophagus Adenocarcinoma;
=Neoplastic Process
85. Esophageal Mucoepidermoid Carcinoma
[A rare carcinoma of the esophagus which contains squamous cells, mucus secreting cells, and cells of an intermediate type. (WHO, 2000) — 2003 ( NCI )] (UMLS (NCI) C1333461) Mucoepidermoid Carcinoma of Esophagus;
Mucoepidermoid Carcinoma of the Esophagus;
Mucoepidermoid Esophageal Carcinoma;
Mucoepidermoid Esophagus Carcinoma =Neoplastic Process
36. Esophageal Adenocarcinoma, Stage I
[Stage 1 includes T1, N0, M0. T1: Tumor invades lamina propria or submucosa; N0: No regional lymph node metastasis; M0: No distance metastasis. (AJCC 6th Edition)-2003 ( NCI )] (UMLS (NCI) C0854765) Oesophageal Adenocarcinoma Stage I;
Stage I Adenocarcinoma of Esophagus;
Stage I Adenocarcinoma of the Esophagus;
Stage I Esophageal Adenocarcinoma;
Stage I Esophagus Adenocarcinoma;
=Neoplastic Process
86. Esophageal Mucosa
(UMLS (NCI) C0227176) =Body Part, Organ, or Organ Component
37. Esophageal Adenocarcinoma, Stage II
[Stage 2 includes T2 or T3, N0, M0 and T1 or T2, N1, M0. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis; N1: Regional lymph node metastasis; M0 No distant metastasis.(AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854763) Oesophageal Adenocarcinoma Stage II;
Stage II Adenocarcinoma of Esophagus;
Stage II Adenocarcinoma of the Esophagus;
Stage II Esophageal Adenocarcinoma;
Stage II Esophagus Adenocarcinoma;
=Neoplastic Process
87. Esophageal Muscular Coat
(UMLS (NCI) C1179500) =Body Part, Organ, or Organ Component ;
38. Esophageal Adenocarcinoma, Stage III
[Stage 3 includes T3,N1,M0/T4,anyN,M0. T4: Tumor invades adjacent structures (from PDQ). ( NCI )] (UMLS (NCI) C0854766) Oesophageal Adenocarcinoma Stage III;
Stage III Adenocarcinoma of Esophagus;
Stage III Adenocarcinoma of the Esophagus;
Stage III Esophageal Adenocarcinoma;
Stage III Esophagus Adenocarcinoma;
=Neoplastic Process
88. Esophageal Muscularis Mucosa
(UMLS (NCI) C0227177) =Body Part, Organ, or Organ Component
39. Esophageal Adenocarcinoma, Stage IV
[Stage 4 includes anyT, anyN, M1or M1a or M1b. M1: Distant metastasis. Tumors of the lower thoracic esophagus. M1a: Metastasis in celiac lymph nodes. M1b: Other distant metastasis. Tumors of the mid-thoracic esophagus. M1a :Not applicable. M1b: Nonregional lymph nodes and/or other distant metastasis. Tumors of the upper thoracic esophagus. M1a: Metastasis in cervical nodes. M1b: Other distant metastasis (from PDQ) ( NCI )] (UMLS (NCI) C1142347) Metastatic Adenocarcinoma of Esophagus;
Metastatic Adenocarcinoma of the Esophagus;
Metastatic Esophageal Adenocarcinoma;
Metastatic Esophagus Adenocarcinoma;
Oesophageal Adenocarcinoma Stage IV;
Stage IV Adenocarcinoma of Esophagus;
Stage IV Adenocarcinoma of the Esophagus;
Stage IV Esophageal Adenocarcinoma;
Stage IV Esophagus Adenocarcinoma =Neoplastic Process
89. Esophageal Neuroendocrine Neoplasm
[These neoplasms are rare in the esophagus, and include carcinoid tumor and small cell carcinoma. (WHO, 2000) — 2003 ( NCI )] (UMLS (NCI) C1333462) Esophageal Neuroendocrine Tumor;
Neuroendocrine Neoplasm of Esophagus;
Neuroendocrine Neoplasm of the Esophagus;
Neuroendocrine Tumor of Esophagus;
Neuroendocrine Tumor of the Esophagus =Neoplastic Process
40. Esophageal Adenosquamous Carcinoma
[A carcinoma that has a significant squamous carcinomatous component that is intermingled with an adenocarcinoma. (WHO, 2000) — 2003 ( NCI )] (UMLS (NCI) C1333442) =Neoplastic Process
90. Esophageal Neurofibroma
[A non-metastasizing encapsulated neoplasm arising from nerves in the esophagus. Morphologically, it is characterized by the presence of fibroblasts and schwann cells. ( NCI )] (UMLS (NCI) C1333463) Esophagus Neurofibroma;
Neurofibroma of Esophagus;
Neurofibroma of the Esophagus =Neoplastic Process
41. ESOPHAGEAL ANOMALY NEC
[ ] (UMLS (ICD9CM) C0029758) =Congenital Abnormality
91. Esophageal Non-Hodgkin Lymphoma
(UMLS (NCI) C1333464) Esophageal Non-Hodgkin's Lymphoma;
Esophagus Non-Hodgkin Lymphoma;
Non-Hodgkin's Esophagus Lymphoma;
Non-Hodgkin's Lymphoma of Esophagus;
Non-Hodgkin's Lymphoma of the Esophagus;
Primary Esophageal Non-Hodgkin's Lymphoma;
=Neoplastic Process
42. Esophageal Artery
(UMLS (NCI) C0226294) =Body Part, Organ, or Organ Component
92. Esophageal Oat Cell Carcinoma
[A neuroendocrine carcinoma that occurs mainly in the sixth to seventh decade; it is as common in males as females. It usually involves the distal half of the esophagus, and dysphagia is the presenting symptom. The prognosis is poor. (WHO, 2000) — 2003 ( NCI )] (UMLS (NCI) C1112474) Esophageal Small Cell Carcinoma;
Esophagus Oat Cell Carcinoma;
Esophagus Small Cell Carcinoma;
Oat Cell Carcinoma of Esophagus;
Oat Cell Carcinoma of the Esophagus;
Small Cell Carcinoma of Esophagus;
Small Cell Carcinoma of the Esophagus;
Small Cell Carcinoma, Esophagus =Neoplastic Process
43. esophageal atresia
[Congenital abnormality characterized by the lack of full development of the ESOPHAGUS that commonly occurs with TRACHEOESOPHAGEAL FISTULA. Symptoms include excessive SALIVATION; GAGGING; CYANOSIS; and DYSPNEA. ( MSH )] (UMLS (CSP) C0014850) =Congenital Abnormality; Disease or Syndrome =Disease of esophagus;
ANOM DIGESTIVE SYST NOS
93. ESOPHAGEAL OPERATION NEC
[ ] (UMLS (ICD9CM) C0176750) =Therapeutic or Preventive Procedure
44. esophageal cancer
[new abnormal esophageal tissue, the portion of the digestive canal between the pharynx and stomach, that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (CSP) C0014859) =Neoplastic Process ;
=digestive neoplasm;
Disease of esophagus;
Digestive Neoplasm;
Head and Neck Neoplasm
94. Esophageal Polyp
(UMLS (NCI) C0281838) =Neoplastic Process ;
45. Esophageal Cancer Prevention
(UMLS (NCI) C0281195) =Therapeutic or Preventive Procedure
95. Esophageal Precancerous Condition
(UMLS (NCI) C1333465) Esophageal Premalignant Condition =Disease or Syndrome
46. Esophageal Cancer Stage I
[Cancer that is found in the lining of the esophagus but has not spread to nearby tissues, lymph nodes, or other organs. ( NCI )] (UMLS (NCI) C0278559) =Neoplastic Process
96. esophageal pressure
[ ] (UMLS (CSP) C0232531) =Organ or Tissue Function
47. Esophageal Cancer Stage II
[Cancer that may be found in all layers of esophageal tissue and may have spread to regional lymph nodes, but has not spread to other tissues. ( NCI )] (UMLS (NCI) C0278560) =Neoplastic Process
97. Esophageal reflux
[(GAS-tro-eh-sof-a-JEE-al REE-flux diz-EEZ) Also called GERD. A common disorder marked by frequent or severe heartburn. The burning feeling occurs when stomach acid flows up into the esophagus. ( NCI )] (UMLS (ICD9CM) C0017168) =Disease or Syndrome =DYSKINESIA OF ESOPHAGUS;
48. Esophageal Cancer Stage IIA
(UMLS (NCI) C1336159) Stage IIA Carcinoma of Esophagus;
Stage IIA Carcinoma of the Esophagus;
Stage IIA Esophageal Cancer;
Stage IIA Esophageal Carcinoma;
Stage IIA Esophagus Carcinoma;
=Neoplastic Process
98. Esophageal Reflux
[The term used when liquid backs up into the esophagus from the stomach. ( NCI )] (UMLS (NCI) C0232483) =Pathologic Function
49. Esophageal Cancer Stage IIB
(UMLS (NCI) C1336181) Stage IIB Carcinoma of Esophagus;
Stage IIB Carcinoma of the Esophagus;
Stage IIB Esophageal Cancer;
Stage IIB Esophageal Carcinoma;
Stage IIB Esophagus Carcinoma =Neoplastic Process
99. ESOPHAGEAL REPAIR NEC
[ ] (UMLS (ICD9CM) C0029722) =Therapeutic or Preventive Procedure
50. Esophageal Cancer Stage III
[Cancer has spread to tissues or lymph nodes near the esophagus but has not spread to other parts of the body. ( NCI )] (UMLS (NCI) C0278561) =Neoplastic Process
100. Esophageal Sarcoma
(UMLS (NCI) C1333466) Esophagus Sarcoma;
Sarcoma of Esophagus;
Sarcoma of the Esophagus;
Sarcoma, Esophagus;
=Neoplastic Process

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM